Hemolytic disease of the newborn due to the Scianna antibody, anti‐Sc2
- 1 January 1995
- journal article
- case report
- Published by Wiley in Transfusion
- Vol. 35 (1) , 58-60
- https://doi.org/10.1046/j.1537-2995.1995.35195090664.x
Abstract
Alloantibodies to the low-frequency antigen Scianna 2 (Sc2) are uncommon and not previously reported to cause immune hemolysis. A group B, Rh-negative infant born to a group B, Rh-positive mother had a 2+ direct antiglobulin test, as well as modest hyperbilirubinemia and a hematocrit of 45 percent. Ongoing immune hemolysis led to a hematocrit of 17.3 percent on Day 20 of life, and the infant required hospitalization and red cell transfusions. The routine maternal antibody screen was negative, but anti-Sc2 was detected during work-up for a low-frequency red cell antigen, and the father's red cells typed as Sc:1,2. Anti-Sc2 can cause clinically significant hemolytic disease of the newborn. Although the antibody is uncommon, its frequency and hemolytic potential may be underappreciated, in part because investigations often are not carried out in the infant whose red cells are ABO-incompatible with maternal blood.Keywords
This publication has 6 references indexed in Scilit:
- Anti‐Sc1 in pregnancyTransfusion, 1990
- The Scianna blood group lies distal to uridine monophosphate kinase on chromosome 1pAnnals of Human Genetics, 1979
- Scianna Blood Group System1Vox Sanguinis, 1974
- On the Blood Group Antigens Bua and SmTransfusion, 1967
- An Antibody Defining a New Blood Group Antigen, Bua*Transfusion, 1963
- A New Antibody, Anti‐Sm, Reacting with A High Incidence AntigenTransfusion, 1962